Nanotech Indonesia Number Of Employees vs. Revenue

NANO Stock   21.00  1.00  5.00%   
Based on the key profitability measurements obtained from Nanotech Indonesia's financial statements, Nanotech Indonesia Global may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Nanotech Indonesia's ability to earn profits and add value for shareholders.
For Nanotech Indonesia profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nanotech Indonesia to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nanotech Indonesia Global utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nanotech Indonesia's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nanotech Indonesia Global over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between Nanotech Indonesia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nanotech Indonesia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nanotech Indonesia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Nanotech Indonesia Global Revenue vs. Number Of Employees Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Nanotech Indonesia's current stock value. Our valuation model uses many indicators to compare Nanotech Indonesia value to that of its competitors to determine the firm's financial worth.
Nanotech Indonesia Global is considered to be number one stock in number of employees category among its peers. It also is rated top company in revenue category among its peers totaling about  514,877,918  of Revenue per Number Of Employees. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nanotech Indonesia's earnings, one of the primary drivers of an investment's value.

Nanotech Number Of Employees vs. Competition

Nanotech Indonesia Global is considered to be number one stock in number of employees category among its peers. The total workforce of Medical Devices industry is now estimated at about 9,570. Nanotech Indonesia maintains roughly 52.0 in number of employees contributing less than 1% to all equities under Medical Devices industry.

Nanotech Revenue vs. Number Of Employees

Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Nanotech Indonesia

Number of Employees

 = 

Full Time

+

Part Time

 = 
52
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Nanotech Indonesia

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
26.77 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Nanotech Revenue vs Competition

Nanotech Indonesia Global is rated top company in revenue category among its peers. Market size based on revenue of Medical Devices industry is now estimated at about 13.83 Trillion. Nanotech Indonesia adds roughly 26.77 Billion in revenue claiming only tiny portion of all equities under Medical Devices industry.

Nanotech Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Nanotech Indonesia. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nanotech Indonesia position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nanotech Indonesia's important profitability drivers and their relationship over time.

Use Nanotech Indonesia in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nanotech Indonesia position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanotech Indonesia will appreciate offsetting losses from the drop in the long position's value.

Nanotech Indonesia Pair Trading

Nanotech Indonesia Global Pair Trading Analysis

The ability to find closely correlated positions to Nanotech Indonesia could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nanotech Indonesia when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nanotech Indonesia - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nanotech Indonesia Global to buy it.
The correlation of Nanotech Indonesia is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nanotech Indonesia moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nanotech Indonesia Global moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nanotech Indonesia can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Nanotech Indonesia position

In addition to having Nanotech Indonesia in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small & Mid Caps ETFs Thematic Idea Now

Small & Mid Caps ETFs
Small & Mid Caps ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Small & Mid Caps ETFs theme has 19 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small & Mid Caps ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Nanotech Stock

To fully project Nanotech Indonesia's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Nanotech Indonesia Global at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Nanotech Indonesia's income statement, its balance sheet, and the statement of cash flows.
Potential Nanotech Indonesia investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Nanotech Indonesia investors may work on each financial statement separately, they are all related. The changes in Nanotech Indonesia's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Nanotech Indonesia's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.